High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy

被引：0
|
作者：
Xiujuan Chang
Yinying Li
Chao Sun
Xiaodong Li
Wenjuan Du
Qinghua Shang
Laicheng Song
Qinghua Long
Qin Li
Huabao Liu
Jing Wang
Zujiang Yu
Jiang Li
Guangming Xiao
Li Li
Liang Chen
Lin Tan
Yongping Chen
Yongping Yang
机构：
[1] Fifth Medical Center of Chinese PLA General Hospital,Department of Hepatology
[2] Chinese PLA Medical School,Department of Research for Clinical Medicine
[3] the Fifth Medical Center of Chinese PLA General Hospital,Discipline and Degree Division
[4] the Graduate School of the PLA General Hospital,Center of Therapeutic Liver Disease
[5] the 88th Hospital of Chinese PLA,Department of Infection and Liver Disease
[6] Traditional Chinese Medicine Hospital of Taihe,Department of Infectious Disease
[7] Yichun People’s Hospital,Department of Infectious Diseases, Southwest Hospital
[8] Fuzhou Infectious Diseases Hospital,Department of Traditional Chinese Medicine, Beijing Youan Hospital
[9] Traditional Chinese Medicine Hospital of Chongqing,Department of Hepatic Diseases
[10] Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University,Department of Liver Disease
[11] the First Affiliated Hospital of Zhengzhou University,Department of Infectious and Liver Diseases, Liver Research Center
[12] Army Military Medical University,undefined
[13] Guangzhou 8th People’s Hospital,undefined
[14] Capital Medical University,undefined
[15] Shanghai Public Health Clinical Center,undefined
[16] Fuyang 2nd People’s Hospital,undefined
[17] the First Affiliated Hospital of Wenzhou Medical University,undefined
来源：
Journal of Gastroenterology | 2023年 / 58卷
关键词：
Hepatocellular carcinoma; Hepatic fibrosis; HBeAg; HBsAg; HBcrAg;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：481 / 493
页数：12
相关论文
共 50 条
  • [1] High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy
    Chang, Xiujuan
    Li, Yinying
    Sun, Chao
    Li, Xiaodong
    Du, Wenjuan
    Shang, Qinghua
    Song, Laicheng
    Long, Qinghua
    Li, Qin
    Liu, Huabao
    Wang, Jing
    Yu, Zujiang
    Li, Jiang
    Xiao, Guangming
    Li, Li
    Chen, Liang
    Tan, Lin
    Chen, Yongping
    Yang, Yongping
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (05) : 481 - 493
  • [2] Hepatic Fibrosis Improvement Does Not Differ Between Type of Antiviral Therapy in Chronic Hepatitis B Patients
    Phan, Quynh-An
    Romero, Ana
    Mohamed, Sadde
    Nguyen, Natalie N.
    Sanchez, Miriam M.
    Egwim, Chukwuma
    Ankoma-Sey, Victor
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S553 - S553
  • [3] Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B
    Lee, Hye Won
    Yip, Terry Cheuk-Fung
    Tse, Yee-Kit
    Wong, Grace Lai-Hung
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Chan, Henry Lik-Yuen
    Ahn, Sang Hoon
    Wong, Vincent Wai-Sun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (09) : 1950 - +
  • [4] THE ASSOCIATION BETWEEN HEPATIC FIBROSIS AND SKELETAL MUSCLE MASS CHANGES DURING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B
    Kim, Kyung Hyun
    Kim, Seung Up
    HEPATOLOGY, 2019, 70 : 589A - 589A
  • [5] Hepatic microRNA as biomarker for detection of hepatocellular carcinoma in high-risk chronic Hepatitis B patients
    Ghosh, Amit
    Ghosh, Alip
    Datta, Somenath
    Dasgupta, Debanjali
    Das, Soumyajit
    Ray, Sukanta
    Gupta, Subash
    Datta, Simanti
    Chowdhury, Abhijit
    Mohapatra, Saroj Kant
    Banerjee, Soma
    CANCER RESEARCH, 2015, 75
  • [6] Performance of fibrosis biomarkers for stratifying hepatocellular carcinoma risk in patients under antiviral therapy for chronic hepatitis B
    Lee, Sang-geul
    Song, Byeong Geun
    Sinn, Dong Hyun
    Kang, Won-seok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2017, 66 : 1014A - 1014A
  • [7] Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
    Lee, Hye Won
    Na, Kiyong
    Kim, Seung Up
    Kim, Beom Kyung
    Park, Jun Yong
    Nahm, Ji Hae
    Lee, Jung Il
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Park, Young Nyun
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [8] Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
    Hye Won Lee
    Kiyong Na
    Seung Up Kim
    Beom Kyung Kim
    Jun Yong Park
    Ji Hae Nahm
    Jung Il Lee
    Do Young Kim
    Sang Hoon Ahn
    Kwang-Hyub Han
    Young Nyun Park
    Scientific Reports, 9
  • [9] Discontinuation of antiviral therapy in chronic hepatitis B patients
    Renato Medas
    Rodrigo Liberal
    Guilherme Macedo
    World Journal of Clinical Cases, 2021, (24) : 6979 - 6986
  • [10] Chronic hepatitis B with advanced fibrosis or cirrhosis: Impact of antiviral therapy
    Arora, Gaurav
    Keeffe, Emmet B.
    REVIEWS IN GASTROENTEROLOGICAL DISORDERS, 2007, 7 (02) : 63 - 73
12345